March 16, 2022

Press Release: ECOG-ACRIN opens a new NCI-MATCH treatment arm for dMMR and LAG-3-positive cancers as it continues to locate patients with BRAF mutations

March 1, 2022

FDA notes the NCI-MATCH trial in its release of new guidance on master protocols and expansion cohorts

April 26, 2021

Press Release: 12 open arms in NCI-MATCH treatment trial await patients with advanced or rare cancers

October 13, 2020

Press Release: Genomic study of 6000 NCI-MATCH cancer patients leads to new clinical trial benchmarks

January 7, 2020

Press Release: NCI-MATCH finds that T-DM1 shows promising activity in salivary gland cancer

December 19, 2019

Press Release: NCI-MATCH finds promising signal for nivolumab beyond colorectal cancer

June 3, 2019

Press Release: NCI-MATCH trial finds the combination of dabrafenib and trametinib effective

June 4, 2018

Press Release: NCI-MATCH precision medicine clinical trial releases new findings

June 7, 2017

Press Release: NCI-MATCH cancer trial reaches 6,000-patient tumor sequencing goal 2 years early

ECOG-ACRIN Cancer Research Group